ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.10
-1.35%
US Tech 100
17,170.80
-3.34%
S&P 500
5,113.10
-3.21%
US Dollar vs CAD
1.38389
0.09%
Bitcoin
87,004.12
2.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Spero Therapeutics Inc (SPRO)

  7. Spero Therapeutics Inc (SPRO) News

SPRO

Spero Therapeutics (SPRO)

Spero Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SPRO
DateTimeSourceHeadlineSymbolCompany
03/27/20254:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
03/27/20253:30PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SPROSpero Therapeutics Inc
03/27/20253:01PMGlobeNewswire Inc.Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
03/18/20257:00AMGlobeNewswire Inc.Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025NASDAQ:SPROSpero Therapeutics Inc
02/28/20254:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
02/25/20259:15AMGlobeNewswire Inc.UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceNASDAQ:SPROSpero Therapeutics Inc
02/25/20256:00AMGlobeNewswire Inc.Spero Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceNASDAQ:SPROSpero Therapeutics Inc
02/05/20258:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
02/05/20257:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
01/10/20256:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
01/10/20256:00AMGlobeNewswire Inc.Spero Therapeutics Provides Business Update and Announces Interim Leadership ChangesNASDAQ:SPROSpero Therapeutics Inc
11/14/20243:05PMGlobeNewswire Inc.Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
11/12/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
11/07/20243:05PMGlobeNewswire Inc.Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024NASDAQ:SPROSpero Therapeutics Inc
10/29/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
10/29/20243:05PMGlobeNewswire Inc.Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
10/16/20243:05PMGlobeNewswire Inc.Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024NASDAQ:SPROSpero Therapeutics Inc
10/02/20243:30PMGlobeNewswire Inc.Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and ChemotherapyNASDAQ:SPROSpero Therapeutics Inc
09/10/20245:56AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
09/04/20243:05PMGlobeNewswire Inc.Spero Therapeutics to Present at Upcoming September Investor ConferencesNASDAQ:SPROSpero Therapeutics Inc
08/29/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
08/29/20245:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
08/29/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
08/06/20246:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPROSpero Therapeutics Inc
08/05/20243:25PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SPROSpero Therapeutics Inc
08/05/20243:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPROSpero Therapeutics Inc
08/05/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPROSpero Therapeutics Inc
08/05/20243:01PMGlobeNewswire Inc.Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business UpdateNASDAQ:SPROSpero Therapeutics Inc
07/29/20243:05PMGlobeNewswire Inc.Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024NASDAQ:SPROSpero Therapeutics Inc
07/03/202412:05PMGlobeNewswire Inc.Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SPROSpero Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SPRO

Your Recent History

LSE
0N9T
Enervit
TSXV
UCU.RT
Ucore Rare Metals
COIN
DFDUSD
DefiDollar DAO
USOTC
SPSO
Spectacular Solar (CE)
BIT
UB5FUR
Unicredit Bank
NASDAQ
INRO
BlackRock ETF Trust iSha...
USOTC
AESO
Atlantic Energy Solutions (PK)
BIT
P11RJ5
BNP PARIBAS ISSUANCE
BIT
UC33Y7
Unicredit Bank
BIT
P1DM60
BNP Paribas Issuance
USOTC
INNX
Infinite Networks (CE)
NASDAQ
BLLD
JP Morgan Sustainable In...
USOTC
SUPCF
Supalai Public (PK)
BIT
UB5UKU
Unicredit Bank
UNSW
TCPETH
The Crypto Prophecies
NYSE
NI
Nisource
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads